Knowledge Graph · Medication
Semaglutide
A GLP-1 receptor agonist medication used for type 2 diabetes and obesity.
Authoritative sources
Evidence base
Randomized Controlled Trial · 2021 · Landmark
Once-Weekly Semaglutide in Adults with Overweight or Obesity
New England Journal of Medicine · Wilding JPH, Batterham RL, Calanna S, et al. (STEP 1)
The pivotal trial that established semaglutide (Wegovy) as a highly effective medication for weight loss in adults without diabetes.
Where Semaglutide appears on Kindr Health
Data hub
Wiki
This page is part of Kindr Health's public Knowledge Graph. Content is for educational purposes only and is not medical advice.